Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||
Cash flow from continuing operating activities | -556.12%-19.6M | 175.11%4.3M | 393.69%1.56M | -531.83K |
Net income from continuing operations | 19.66%-5.49M | -156.46%-6.83M | -171.50%-2.66M | ---981.04K |
Operating gains losses | ---- | --16.92K | ---- | ---- |
Depreciation and amortization | -6.33%721.45K | 459.79%770.21K | 211.50%137.59K | --44.17K |
Other non cash items | --9.23K | ---- | -57.34%150.64K | --353.13K |
Change In working capital | -241.20%-14.74M | 188.11%10.44M | 6,881.20%3.62M | --51.91K |
-Change in receivables | -740.09%-926.85K | -259.58%-110.33K | 189.88%69.14K | ---76.92K |
-Change in prepaid assets | ---111.46K | --0 | ---119.55K | --0 |
-Change in payables and accrued expense | -193.56%-10.94M | 2,752.71%11.69M | 194.73%409.76K | --139.03K |
-Change in other current liabilities | ---68.87K | --0 | 55.75%-188.72K | ---426.51K |
-Change in other working capital | -137.12%-2.7M | -132.96%-1.14M | 729.48%3.45M | --416.32K |
Cash from discontinued investing activities | ||||
Operating cash flow | -556.12%-19.6M | 175.11%4.3M | 393.69%1.56M | ---531.83K |
Investing cash flow | ||||
Cash flow from continuing investing activities | 99.17%-82.97K | -2,753.21%-10.05M | 142.02%378.73K | -901.24K |
Net PPE purchase and sale | -71.31%-82.97K | -90.27%-48.43K | 72.35%-25.46K | ---92.07K |
Net business purchase and sale | --0 | ---10M | --0 | --0 |
Net other investing changes | ---- | ---- | 149.95%404.18K | ---809.17K |
Cash from discontinued investing activities | ||||
Investing cash flow | 99.17%-82.97K | -2,753.21%-10.05M | 142.02%378.73K | ---901.24K |
Financing cash flow | ||||
Cash flow from continuing financing activities | 741.47%57.85M | 1,292.24%6.87M | -121.17%-576.62K | 2.72M |
Net issuance payments of debt | 201.07%797.23K | -46.45%-788.82K | -119.78%-538.62K | --2.72M |
Net common stock issuance | 341.12%44.11M | --10M | --0 | --0 |
Net other financing activities | 653.74%12.94M | -6,049.07%-2.34M | ---38K | ---- |
Cash from discontinued financing activities | ||||
Financing cash flow | 741.47%57.85M | 1,292.24%6.87M | -121.17%-576.62K | --2.72M |
Net cash flow | ||||
Beginning cash position | 44.81%3.63M | 74.31%2.51M | 875.34%1.44M | --147.41K |
Current changes in cash | 3,298.29%38.17M | -17.66%1.12M | 5.71%1.36M | --1.29M |
Effect of exchange rate changes | ---- | ---- | ---- | --0 |
End cash Position | 1,051.60%41.8M | 29.54%3.63M | 94.87%2.8M | --1.44M |
Free cash flow | -563.27%-19.68M | 176.51%4.25M | 346.27%1.54M | ---623.9K |
Currency Unit | HKD | HKD | HKD | HKD |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- |